- Veterinary parasiticides, essential for the prevention and treatment of parasitic infections in animals, are increasingly vital in ensuring animal health, improving livestock productivity, and supporting the well-being of companion animals. Their role is becoming more prominent due to heightened awareness, regulatory support, and advancements in veterinary care
- The escalating demand for veterinary parasiticides is primarily fueled by the growing incidence of zoonotic diseases, increasing pet ownership, and the intensification of livestock farming practices across the globe. The development of broad-spectrum parasiticides and combination treatments further supports market expansion
- North America dominated the veterinary parasiticides market with the largest revenue share of 38.10% in 2024, driven by a well-established veterinary healthcare infrastructure, rising adoption of companion animals, and significant investment in animal health R&D. The U.S. leads the region’s growth with increased usage of advanced parasiticide products and strong veterinary pharmaceutical industry presence
- Asia-Pacific is expected to be the fastest-growing region with CAGR 12.4% in the Veterinary Parasiticides market during the forecast period, fueled by increasing livestock production, government-led animal health initiatives, and a surge in demand for pet healthcare due to rising disposable incomes and urbanization
- Ectoparasiticides segment dominated the veterinary parasiticides market with a market share of 41.3% in 2024, driven by their widespread use in controlling fleas, ticks, and lice across both livestock and companion animals. Their fast-acting properties and ease of topical administration continue to make them a preferred choice for effective parasite control among veterinarians and pet owners
